Researchers have discovered that the Covid-19 virus can trigger the immune system to attack cancer cells. The virus's RNA ...

Immune cells produced during severe COVID-19 infection may shrink tumors. The unexpected mechanism offers a new therapeutic ...

The researchers' recently published study describes a way to re-activate apoptosis in mutated cells, which would amount to ...

Researchers at the University of Toronto’s Faculty of Applied Science & Engineering have designed a new microfluidic platform ...

In recent years, scientists have created a range of new methods based on CRISPR-Cas technology for precisely editing the ...

Researchers at the University of Toronto's Faculty of Applied Science & Engineering have designed a new microfluidic platform ...

On the wall of Dian Yang's office hangs a painting of a "Pandora's box of cancer" being opened with a molecular key. From ...

A novel test developed by Duke-NUS researchers enables real-time monitoring of T cells that have been engineered to fight ...

Researchers at ETH Zurich combined two CRISPR-Cas methods to decipher how mutations in a cell’s genome affect its function.

In drug discovery, targeted protein degradation is a method that selectively eliminates disease-causing proteins. A ...

Non-alcoholic fatty liver disease (NAFLD) has emerged as a growing concern in liver cancer development. This condition, often ...